The following bibliography has been generated by bringing together all references provided by our content partners. There may be duplication.


  • Bock, P.; Gordon, D. (2013). WoRMS Bryozoa: World List of Bryozoa (version 2013-03-04). In: Species 2000 & ITIS Catalogue of Life, 11th March 2013 (Roskov Y., Kunze T., Paglinawan L., Orrell T., Nicolson D., Culham A., Bailly N., Kirk P., Bourgoin T., Baillargeon G., Hernandez F., De Wever A., eds). Digital resource at Species 2000: Reading, UK.
  • De Blauwe, H. (2009). Mosdiertjes van de Zuidelijke Bocht van de Noordzee. Determinatiewerk voor België en Nederland. Uitgave Vlaams Instituut voor de Zee, Oostende: 464pp.
  • Dr.Jay Vavra, High Tech High School, San Diego, CA
  • Gordon, D. (2014). Bugula neritina (Linnaeus, 1758). In: Bock, P.; Gordon, D. (2014) World List of Bryozoa. Accessed through: World Register of Marine Species at
  • Kraft AS, Smith JB, Berkow RL. (1986). Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci USA 83: 1334–1338.
  • Kuzirian AM, Epstein HT, Gagliardi CJ, Nelson TJ, Sakakibara M, Taylor C et al. (2006). Bryostatin enhancement of memory in Hermissenda. Biol Bull 210: 201–214.
  • LE GRANCHÉ Philippe, ANDRÉ Frédéric, in : DORIS, 15/3/2013 : Bugula neritina (Linnaeus, 1758),
  • Lindquist N, Hay ME. (1996). Palatability and chemical defense of marine invertebrate larvae. Ecol Monogr 66: 431–450.
  • Linnaeus, C. (1758). Systema Naturae per regna tria naturae, secundum classes, ordines, genera, species, cum characteribus, differentiis, synonymis, locis. Editio decima, reformata. Laurentius Salvius: Holmiae. ii, 824 pp.
  • Parkinson DR, Arbuck SG, Moore T, Pluda JM, Christian MC. (1994). Clinical development of anticancer agents from natural products. Stem Cells 12: 30–43.
  • Sharp, Koty H., Seana K. Davidson, and Margo G. Haygood. "Localization of ‘Candidatus Endobugula sertula’and the bryostatins throughout the life cycle of the bryozoan Bugula neritina." The ISME journal 1.8 (2007): 693-702.
  • Sun MK, Alkon DL. (2005). Dual effects of bryostatin-1 on spatial memory and depression. Eur J Pharmacol 525: 171.
  • Sun MK, Alkon DL. (2006). Bryostatin 1: pharmacology and therapeutic potential as a CNS drug. CNS Drug Rev 12: 1–8.


EOL content is automatically assembled from many different content providers. As a result, from time to time you may find pages on EOL that are confusing.

To request an improvement, please leave a comment on the page. Thank you!